450 related articles for article (PubMed ID: 21865693)
41. IgA nephropathy and Henoch-Schoenlein purpura nephritis: aberrant glycosylation of IgA1, formation of IgA1-containing immune complexes, and activation of mesangial cells.
Novak J; Moldoveanu Z; Renfrow MB; Yanagihara T; Suzuki H; Raska M; Hall S; Brown R; Huang WQ; Goepfert A; Kilian M; Poulsen K; Tomana M; Wyatt RJ; Julian BA; Mestecky J
Contrib Nephrol; 2007; 157():134-8. PubMed ID: 17495451
[TBL] [Abstract][Full Text] [Related]
42. Role of aberrant glycosylation of IgA1 molecules in the pathogenesis of IgA nephropathy.
Mestecky J; Tomana M; Moldoveanu Z; Julian BA; Suzuki H; Matousovic K; Renfrow MB; Novak L; Wyatt RJ; Novak J
Kidney Blood Press Res; 2008; 31(1):29-37. PubMed ID: 18182777
[TBL] [Abstract][Full Text] [Related]
43. Development of immunoglobulin A nephropathy- like disease in beta-1,4-galactosyltransferase-I-deficient mice.
Nishie T; Miyaishi O; Azuma H; Kameyama A; Naruse C; Hashimoto N; Yokoyama H; Narimatsu H; Wada T; Asano M
Am J Pathol; 2007 Feb; 170(2):447-56. PubMed ID: 17255313
[TBL] [Abstract][Full Text] [Related]
44. Expression of IgA class switching gene in tonsillar mononuclear cells in patients with IgA nephropathy.
Liu H; Peng Y; Liu F; Xiao W; Zhang Y; Li W
Inflamm Res; 2011 Sep; 60(9):869-78. PubMed ID: 21614556
[TBL] [Abstract][Full Text] [Related]
45. Enzymatically deglycosylated human IgA1 molecules accumulate and induce inflammatory cell reaction in rat glomeruli.
Sano T; Hiki Y; Kokubo T; Iwase H; Shigematsu H; Kobayashi Y
Nephrol Dial Transplant; 2002 Jan; 17(1):50-6. PubMed ID: 11773462
[TBL] [Abstract][Full Text] [Related]
46. Sparsentan ameliorates glomerular hypercellularity and inflammatory-gene networks induced by IgA1-IgG immune complexes in a mouse model of IgA nephropathy.
Reily C; Moldoveanu Z; Pramparo T; Hall S; Huang ZQ; Rice T; Novak L; Komers R; Jenkinson CP; Novak J
Am J Physiol Renal Physiol; 2024 May; 326(5):F862-F875. PubMed ID: 38511222
[TBL] [Abstract][Full Text] [Related]
47. Association Between Galactose-Deficient IgA1 Derived From the Tonsils and Recurrence of IgA Nephropathy in Patients Who Underwent Kidney Transplantation.
Kawabe M; Yamamoto I; Yamakawa T; Katsumata H; Isaka N; Katsuma A; Nakada Y; Kobayashi A; Koike K; Ueda H; Tanno Y; Koike Y; Miki J; Yamada H; Kimura T; Ohkido I; Tsuboi N; Yamamoto H; Kojima H; Yokoo T
Front Immunol; 2020; 11():2068. PubMed ID: 33013875
[No Abstract] [Full Text] [Related]
48. Aberrant Glycosylation of the IgA1 Molecule in IgA Nephropathy.
Novak J; Barratt J; Julian BA; Renfrow MB
Semin Nephrol; 2018 Sep; 38(5):461-476. PubMed ID: 30177018
[TBL] [Abstract][Full Text] [Related]
49. Pathogenic role of glycan-specific IgG antibodies in IgA nephropathy.
Zhao YF; Zhu L; Liu LJ; Shi SF; Lv JC; Zhang H
BMC Nephrol; 2017 Sep; 18(1):301. PubMed ID: 28969604
[TBL] [Abstract][Full Text] [Related]
50. Compositional similarity between immunoglobulins binding to asialo-, agalacto-IgA1-Sepharose and those deposited in glomeruli in IgA nephropathy.
Takatani T; Iwase H; Itoh A; Nakamura I; Hayashi M; Sakamoto H; Kamata K; Kobayashi Y; Hiki Y; Okamoto M; Higashihara M
J Nephrol; 2004; 17(5):679-86. PubMed ID: 15593035
[TBL] [Abstract][Full Text] [Related]
51. Abnormalities of glycogenes in tonsillar lymphocytes in IgA nephropathy.
Inoue T; Sugiyama H; Kitagawa M; Takiue K; Morinaga H; Kikumoto Y; Maeshima Y; Fukushima K; Nishizaki K; Akagi H; Hiki Y; Makino H
Adv Otorhinolaryngol; 2011; 72():71-4. PubMed ID: 21865694
[TBL] [Abstract][Full Text] [Related]
52. Self-aggregated deglycosylated IgA1 with or without IgG were associated with the development of IgA nephropathy.
Yan Y; Xu LX; Zhang JJ; Zhang Y; Zhao MH
Clin Exp Immunol; 2006 Apr; 144(1):17-24. PubMed ID: 16542360
[TBL] [Abstract][Full Text] [Related]
53. Increase in B-cell-activation factor (BAFF) and IFN-gamma productions by tonsillar mononuclear cells stimulated with deoxycytidyl-deoxyguanosine oligodeoxynucleotides (CpG-ODN) in patients with IgA nephropathy.
Goto T; Bandoh N; Yoshizaki T; Nozawa H; Takahara M; Ueda S; Hayashi T; Harabuchi Y
Clin Immunol; 2008 Mar; 126(3):260-9. PubMed ID: 18249037
[TBL] [Abstract][Full Text] [Related]
54. Paradigm shift in activity assessment of IgA nephropathy - optimizing the next generation of diagnostic and therapeutic maneuvers via glycan targeting.
Suzuki Y; Suzuki H; Yasutake J; Tomino Y
Expert Opin Biol Ther; 2015 Apr; 15(4):583-93. PubMed ID: 25604055
[TBL] [Abstract][Full Text] [Related]
55. Recognition of galactose-deficient O-glycans in the hinge region of IgA1 by N-acetylgalactosamine-specific snail lectins: a comparative binding study.
Gomes MM; Suzuki H; Brooks MT; Tomana M; Moldoveanu Z; Mestecky J; Julian BA; Novak J; Herr AB
Biochemistry; 2010 Jul; 49(27):5671-82. PubMed ID: 20507092
[TBL] [Abstract][Full Text] [Related]
56. Glyco-engineering for the production of recombinant IgA1 with distinct mucin-type O-glycans in plants.
Dicker M; Maresch D; Strasser R
Bioengineered; 2016 Nov; 7(6):484-489. PubMed ID: 27333379
[TBL] [Abstract][Full Text] [Related]
57. Progress in the pathogenesis of IgA nephropathy.
Julian BA; Tomana M; Novak J; Mestecky J
Adv Nephrol Necker Hosp; 1999; 29():53-72. PubMed ID: 10561737
[TBL] [Abstract][Full Text] [Related]
58. IgA nephropathy enigma.
Mestecky J; Novak J; Moldoveanu Z; Raska M
Clin Immunol; 2016 Nov; 172():72-77. PubMed ID: 27444044
[TBL] [Abstract][Full Text] [Related]
59. Tonsillar immunology in IgA nephropathy.
Yang X; Zhu A; Meng H
Pathol Res Pract; 2020 Jul; 216(7):153007. PubMed ID: 32534712
[TBL] [Abstract][Full Text] [Related]
60. Analysis of IgA1 O-glycans in IgA nephropathy by fluorophore-assisted carbohydrate electrophoresis.
Allen AC; Bailey EM; Barratt J; Buck KS; Feehally J
J Am Soc Nephrol; 1999 Aug; 10(8):1763-71. PubMed ID: 10446944
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
